Innovation Unit

"Together, we will discover and develop breakthrough medicines that will change the lives of patients now, and in generations to come."

Soeren Tullin , Head of Global Cardiometabolic Diseases Research

first4patients. By building on our strength and by applying emergent science, we deliver breakthrough therapies for patients with unmet needs by developing drug candidates to save high quality drug products. We collaborate globally, explore and push for provision of robust, scalable processes which are cost and resource efficient to facilitate rapid registration and successful launch of our first in class medications for patients with unmet need.